| 000 | 01780 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516133100.0 | ||
| 264 | 0 | _c20130730 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1179-1926 | ||
| 024 | 7 |
_a10.1007/s40262-013-0032-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNoetzli, Muriel | |
| 245 | 0 | 0 |
_aPopulation pharmacokinetic study of memantine: effects of clinical and genetic factors. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _cMar 2013 |
||
| 300 |
_a211-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 | _aConstitutive Androstane Receptor |
| 650 | 0 | 4 |
_aDementia _xdrug therapy |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMemantine _xblood |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xgenetics |
| 700 | 1 | _aGuidi, Monia | |
| 700 | 1 | _aEbbing, Karsten | |
| 700 | 1 | _aEyer, Stephan | |
| 700 | 1 | _aWilhelm, Laurence | |
| 700 | 1 | _aMichon, Agnès | |
| 700 | 1 | _aThomazic, Valérie | |
| 700 | 1 | _aAlnawaqil, Abdel-Messieh | |
| 700 | 1 | _aMaurer, Sophie | |
| 700 | 1 | _aZumbach, Serge | |
| 700 | 1 | _aGiannakopoulos, Panteleimon | |
| 700 | 1 | _avon Gunten, Armin | |
| 700 | 1 | _aCsajka, Chantal | |
| 700 | 1 | _aEap, Chin B | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 52 _gno. 3 _gp. 211-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40262-013-0032-2 _zAvailable from publisher's website |
| 999 |
_c22468360 _d22468360 |
||